Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fosfomycin Versus Ciprofloxacin for Febrile Neutropenia Prophylaxis in High-risk Haematological Patients (FOVOCIP): a Phase 3, Open-label, Multicentre, Randomised, Non-inferiority Trial.

NCT07616635 is registered in ClinicalTrials.gov with Fundación para la Investigación Biosanitaria del Principado de Asturias as lead sponsor.

NCT NCT07616635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07616635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fosfomycin Versus Ciprofloxacin for Febrile Neutropenia Prophylaxis in High-risk Haematological Patients (FOVOCIP): a Phase 3, Open-label, Multicentre, Randomised, Non-inferiority Trial.
Lead sponsor
Fundación para la Investigación Biosanitaria del Principado de Asturias
Phase
Phase 3
Overall status
Completed
Start date
March 14, 2022
Completion date
December 1, 2024
Enrollment
177 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia, haematopoietic stem cell transplantation